• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SAGE IN-VITRO FERTILIZATION INC. PURCEPTION 80 PERCENT LOWER PHASE GRANDIENT; PURECEPTION MEDIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SAGE IN-VITRO FERTILIZATION INC. PURCEPTION 80 PERCENT LOWER PHASE GRANDIENT; PURECEPTION MEDIA Back to Search Results
Catalog Number ART-2080
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Pain (1994); Toxicity (2333)
Event Date 07/15/2014
Event Type  Injury  
Event Description
"we have received complaint from the israeli health ministry that in one of our sperm laboratory unit, three women were insemination (iui) from sperm donations and almost immediately after injection (after half an hour) developed intense pain in the lower abdomen and leukocytes from 14 to 18 thousand, the sperm donations were from different donors, there were no similar cases in the past, the injection was prepared by different employees and medical staff believes that due to the rapid development of symptoms it seems to them that the cause is not a bacterial infection but rather atoxic response.".
 
Manufacturer Narrative
(b)(4).Conclusion: an assignable caused could not be determined as the products met all approved release specification at the time of manufacture before they were released.Based on review of all the information gathered during this investigation-associated sage documentation, manufacturing process, complaint history, and inspection of current inventory/retention sample, several external sources may have contributed to the reported complaint condition.Potential sources of product contamination include re-staging activities prior to procedure, the catheter used, or improper washing of the sperm samples (see fishbone diagram above).The retention samples of the subject lots tested show that the product meets all approved release specifications.The customer did not return the actual samples involved.The product performs as intended.No further actions are needed at this time.The investigation may be reevaluated with any new additional information received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PURCEPTION 80 PERCENT LOWER PHASE GRANDIENT
Type of Device
PURECEPTION MEDIA
Manufacturer (Section D)
SAGE IN-VITRO FERTILIZATION INC.
pasadena CA
Manufacturer Contact
nana banafo
75 corporate dr
trumbull, CT 06611
2036015200
MDR Report Key4058347
MDR Text Key4811584
Report Number2031459-2014-00002
Device Sequence Number1
Product Code MQL
Combination Product (y/n)N
Reporter Country CodeIS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 07/15/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/16/2015
Device Catalogue NumberART-2080
Device Lot NumberD197 C
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/15/2015
Initial Date FDA Received08/06/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/16/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-